• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将舒张期不同步作为单纯左心室融合起搏心脏再同步治疗中良好反应预测指标的研究

Considering Diastolic Dyssynchrony as a Predictor of Favorable Response in LV-Only Fusion Pacing Cardiac Resynchronization Therapy.

作者信息

Gurgu Andra, Luca Constantin-Tudor, Vacarescu Cristina, Petrescu Lucian, Goanta Emilia-Violeta, Lazar Mihai-Andrei, Arnăutu Diana-Aurora, Cozma Dragos

机构信息

Cardiology Department, "Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania.

Research Center of the Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania.

出版信息

Diagnostics (Basel). 2023 Mar 21;13(6):1186. doi: 10.3390/diagnostics13061186.

DOI:10.3390/diagnostics13061186
PMID:36980494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10047065/
Abstract

CRT improves systolic and diastolic function, increasing cardiac output. Aim of the study: to assess the outcome of LV diastolic dyssynchrony in a population of fusion pacing CRT. Diastolic dyssynchrony was measured by offline speckle-tracking-derived TDI timing assessment of the simultaneity of E″ and A″ basal septal and lateral walls. New parameters introduced: E″ and, respectively, A″ time (E″T/A″T) as the time difference between E″ (respectively, A″) peak septal and lateral wall. Patients were divided into super-responders (SR), responders (R), and non-responders (NR). Baseline characteristics: 62 pts (62 ± 11 y.o.) with idiopathic DCM, EF 27 ± 5.2%; 29% type III diastolic dysfunction (DD), 63% type II, 8% type I. Average follow-up 45 ± 19 months: LVEF 37 ± 7.9%, 34%SR, 61%R, 5%NR. The E″T decreased from 90 ± 20 ms to 25 ± 10 ms in SR with significant LV reverse remodeling (LV end-diastolic volume 193.7 ± 81 vs. 243.2 ± 82 mL at baseline, < 0.0028) and lower LV filling pressures (E/E' 13.2 ± 4.6 vs. 11.4 ± 4.5, = 0.0295). DD profile improved in 65% of R with a reduction in E/E' ratio (21 ± 9 vs. 14 ± 4 ms, < 0.0001). Significant cut-off value calculated by ROC curve for LV diastolic dyssynchrony is E″T > 80 ms and A″T > 30 msec. The study identifies the cut-off values of diastolic dyssynchrony parameters as predictors of favorable outcomes in responders and super-responder patients with fusion CRT pacing. These findings may have important implications in patient selection and follow-up.

摘要

心脏再同步治疗(CRT)可改善心脏的收缩和舒张功能,增加心输出量。本研究目的:评估融合起搏CRT人群中左心室舒张不同步的结果。舒张不同步通过离线斑点追踪衍生的组织多普勒成像(TDI)对室间隔和侧壁基底段E″和A″同步性的定时评估来测量。引入新参数:E″时间(E″T)和A″时间(A″T),分别为室间隔和侧壁E″(分别为A″)峰值之间的时间差。患者分为超反应者(SR)、反应者(R)和无反应者(NR)。基线特征:62例特发性扩张型心肌病患者(年龄62±11岁),射血分数(EF)为27±5.2%;29%为III型舒张功能障碍(DD),63%为II型,8%为I型。平均随访45±19个月:左心室射血分数(LVEF)为37±7.9%,34%为SR,61%为R,5%为NR。在有显著左心室逆向重构的SR患者中,E″T从90±20毫秒降至25±10毫秒(左心室舒张末期容积基线时为193.7±81 vs. 243.2±82毫升,<0.0028),左心室充盈压降低(E/E'为13.2±4.6 vs. 11.4±4.5,=0.0295)。65%的R患者DD情况改善,E/E'比值降低(21±9 vs. 14±4毫秒,<0.0001)。通过ROC曲线计算出的左心室舒张不同步的显著临界值为E″T>80毫秒和A″T>30毫秒。该研究确定了舒张不同步参数的临界值,作为融合CRT起搏反应者和超反应者患者良好预后的预测指标。这些发现可能对患者选择和随访具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/0e7ca9ec2f55/diagnostics-13-01186-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/d6a94ed0220f/diagnostics-13-01186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/2180dea87031/diagnostics-13-01186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/f4663ce77541/diagnostics-13-01186-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/0e7ca9ec2f55/diagnostics-13-01186-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/d6a94ed0220f/diagnostics-13-01186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/2180dea87031/diagnostics-13-01186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/f4663ce77541/diagnostics-13-01186-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6d/10047065/0e7ca9ec2f55/diagnostics-13-01186-g004.jpg

相似文献

1
Considering Diastolic Dyssynchrony as a Predictor of Favorable Response in LV-Only Fusion Pacing Cardiac Resynchronization Therapy.将舒张期不同步作为单纯左心室融合起搏心脏再同步治疗中良好反应预测指标的研究
Diagnostics (Basel). 2023 Mar 21;13(6):1186. doi: 10.3390/diagnostics13061186.
2
Are changes in the extent of left ventricular dyssynchrony as assessed by speckle tracking associated with response to cardiac resynchronization therapy?通过斑点追踪评估的左心室不同步程度的变化是否与心脏再同步治疗的反应相关?
Int J Cardiovasc Imaging. 2016 Apr;32(4):553-61. doi: 10.1007/s10554-015-0809-5. Epub 2015 Nov 19.
3
Cardiac resynchronization therapy in patients with heart failure and narrow QRS complexes (≤ 130 ms): role of speckle tracking echocardiography and different interventricular (VV) pacing intervals.心力衰竭伴窄 QRS 波群(≤130ms)患者的心脏再同步治疗:斑点追踪超声心动图和不同的室间(VV)起搏间期的作用。
J Interv Card Electrophysiol. 2022 Mar;63(2):369-377. doi: 10.1007/s10840-021-01021-y. Epub 2021 Jun 17.
4
Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy.通过斑点追踪应变成像评估左心室不同步:心脏再同步治疗中纵向、圆周和径向应变的比较
J Am Coll Cardiol. 2008 May 20;51(20):1944-52. doi: 10.1016/j.jacc.2008.02.040.
5
Novel algorithm for quantitative assessment of left ventricular dyssynchrony with ECG-gated myocardial perfusion SPECT: useful technique for management of cardiac resynchronization therapy.基于心电图门控心肌灌注 SPECT 的左心室失同步定量评估新算法:心脏再同步治疗管理的有用技术。
Ann Nucl Med. 2011 Dec;25(10):768-76. doi: 10.1007/s12149-011-0525-8. Epub 2011 Aug 13.
6
Long-term follow-up of cardiac resynchronization therapy: mechanical resynchronization and reverse left ventricular remodeling are predictive for long-term transplant-free survival.心脏再同步治疗的长期随访:机械性再同步和逆向左心室重构可预测长期免于移植的存活率。
Int J Cardiovasc Imaging. 2012 Aug;28(6):1341-50. doi: 10.1007/s10554-011-9946-7. Epub 2011 Oct 1.
7
Assessment of intraventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy: comparison between tissue Doppler imaging and real-time three-dimensional echocardiography.评估心室内机械不同步及预测心脏再同步治疗反应:组织多普勒成像与实时三维超声心动图的比较
J Am Soc Echocardiogr. 2009 Sep;22(9):1047-54. doi: 10.1016/j.echo.2009.06.012. Epub 2009 Jul 31.
8
Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.重度充血性心力衰竭患者心脏再同步治疗后左心室逆向重构的预测参数
Ital Heart J. 2005 Sep;6(9):734-9.
9
Left ventricular systolic torsion correlates global cardiac performance during dyssynchrony and cardiac resynchronization therapy.左心室收缩扭转与不同步和心脏再同步治疗期间的整体心脏功能相关。
Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H853-8. doi: 10.1152/ajpheart.00177.2010. Epub 2010 Dec 17.
10
The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results.四极导线左心室多点起搏改善急性血液动力学和径向应变斑点追踪评估的机械不同步:初步结果。
Europace. 2016 Apr;18(4):560-7. doi: 10.1093/europace/euv211. Epub 2015 Sep 1.

引用本文的文献

1
The Functional and Imaging Implications of Left Bundle Branch Pacing in Ischemic Cardiomyopathy.左束支起搏在缺血性心肌病中的功能及影像学意义
Biomolecules. 2025 Mar 26;15(4):489. doi: 10.3390/biom15040489.
2
Speckle Tracking Echocardiography in Patients with Non-Ischemic Dilated Cardiomyopathy Who Undergo Cardiac Resynchronization Therapy: A Narrative Review.接受心脏再同步治疗的非缺血性扩张型心肌病患者的斑点追踪超声心动图:一项叙述性综述。
Diagnostics (Basel). 2024 Jun 3;14(11):1178. doi: 10.3390/diagnostics14111178.
3
Feasibility study on cardiac resynchronization in the treatment of heart failure by single left bundle branch pacing.

本文引用的文献

1
The Interplay of PR Interval and AV Pacing Delays Used for Cardiac Resynchronization Therapy in Heart Failure Patients: Association with Clinical Response in a Retrospective Analysis of a Large Observational Study.心力衰竭患者心脏再同步治疗中PR间期与房室起搏延迟的相互作用:一项大型观察性研究的回顾性分析中与临床反应的关联
J Pers Med. 2022 Sep 15;12(9):1512. doi: 10.3390/jpm12091512.
2
Nonischemic Super-Responders in Fusion CRT Pacing with Normal Atrioventricular Conduction.正常房室传导的融合CRT起搏中的非缺血性超反应者
Diagnostics (Basel). 2022 Aug 23;12(9):2032. doi: 10.3390/diagnostics12092032.
3
Betablockers and Ivabradine Titration According to Exercise Test in LV Only Fusion CRT Pacing.
单左束支起搏治疗心力衰竭的心脏再同步化的可行性研究。
Sci Rep. 2023 Dec 14;13(1):22202. doi: 10.1038/s41598-023-48820-z.
仅左心室融合CRT起搏中根据运动试验调整β受体阻滞剂和伊伐布雷定剂量
Diagnostics (Basel). 2022 Apr 27;12(5):1096. doi: 10.3390/diagnostics12051096.
4
Effect of dynamic atrioventricular and interventricular delay optimization for cardiac resynchronization therapy on cardiac function and neuroendocrine factors in patients with congestive heart failure.动态房室和室内延迟优化用于心脏再同步治疗对充血性心力衰竭患者心功能和神经内分泌因子的影响
Arch Med Sci. 2021 Feb 26;17(2):551-556. doi: 10.5114/aoms/131564. eCollection 2021.
5
Improving Cardiac Resynchronisation Therapy.改善心脏再同步治疗
Arrhythm Electrophysiol Rev. 2019 Jul;8(3):220-227. doi: 10.15420/aer.2018.62.3.
6
Exercise test is essential in LV-only fusion CRT pacing without right ventricle lead.对于仅有左心室融合的 CRT 起搏且无右心室导线的患者,运动试验是必不可少的。
Clin Interv Aging. 2019 Jun 4;14:969-975. doi: 10.2147/CIA.S206251. eCollection 2019.
7
CRT Pacing: Midterm Follow-Up in LV Only Pacing without RV Lead in Patients with Normal AV Conduction.心脏再同步化治疗起搏:正常房室传导患者无右心室导线单纯左心室起搏的中期随访
J Clin Med. 2018 Dec 8;7(12):531. doi: 10.3390/jcm7120531.
8
Ventricular pacing - Electromechanical consequences and valvular function.心室起搏——机电后果与瓣膜功能
Indian Pacing Electrophysiol J. 2016 Jan-Feb;16(1):19-30. doi: 10.1016/j.ipej.2016.02.013. Epub 2016 Mar 4.
9
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).2013年欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗指南:欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗特别工作组。与欧洲心律协会(EHRA)合作制定。
Europace. 2013 Aug;15(8):1070-118. doi: 10.1093/europace/eut206. Epub 2013 Jun 24.
10
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.2012年欧洲心律学会/美国心律学会关于心力衰竭心脏再同步治疗的专家共识声明:植入与随访建议及管理
Europace. 2012 Sep;14(9):1236-86. doi: 10.1093/europace/eus222.